Green Lifescience그린생명과학
114450 · KOSDAQ · ₩114450 · 그린생명과학
- Market cap
- ₩43B
- Enterprise value
- ₩34B
- P/E
- 9.7×
- P/B
- 1.0×
- Dividend yield
- 0.0%
- ROE
- 9.9%
- Net margin
- 7.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−52.9% from the high
₩1,673Today: ₩2,130 – ₩2,220₩4,590
Returns
- 1W−5.9%
- 1M−1.8%
- 3M−3.6%
- 6M−27.4%
- YTD−25.5%
- 1Y−12.0%
- Volume today
- 73,904
- 0.2× the 20-day average
- Traded today
- ₩159M
- Listed shares
- 20,000,000
- EPS (12 months)
- ₩223
- Earnings yield 10.3%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat-1.8% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Green Lifescience stock overview
Green Lifescience (그린생명과학, KRX: 114450) is listed on KOSDAQ, in the Biotech & Pharma sector. The company develops, manufactures and sells precision chemical materials, including active pharmaceutical ingredients, pharmaceutical intermediates, electronic materials and crop protection chemicals. Its shares closed at ₩2,160 on Oct 27, 2026, down 0.69% on the day, giving it a market value of ₩43B.
Key facts
- Market cap
- ₩43B
- Sector
- Biotech & Pharma
- Latest price change
- −0.69%
- As of
- Oct 27, 2026
- Main business
- The company develops, manufactures and sells precision chemical materials, including active pharmaceutical ingredients, pharmaceutical intermediates, electronic materials and crop protection chemicals.
Quick answers about Green Lifescience
- What does Green Lifescience do?
- The company develops, manufactures and sells precision chemical materials, including active pharmaceutical ingredients, pharmaceutical intermediates, electronic materials and crop protection chemicals. It supplies raw materials and intermediates to global pharmaceutical and materials companies, including contract manufacturing for multinational clients using multi-step synthesis and large-scale reaction facilities. It also supplies semiconductor and display-related chemical materials, and it operates production in South Korea.
- What is the market cap of Green Lifescience?
- The market capitalisation of Green Lifescience was ₩43B at the close on Oct 27, 2026.
- Who are the largest shareholders of Green Lifescience?
- According to the latest official filings, the largest reported holders are Gwanak Sangsa (28.48%, as of Jul 29, 2026); Green Chemical (14.67%, as of Jul 31, 2026); Geondeok Trading (0.81%, as of Apr 14, 2025).
- When is the next earnings report from Green Lifescience?
- Korean companies rarely announce results dates in advance. Based on when Green Lifescience filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company develops, manufactures and sells precision chemical materials, including active pharmaceutical ingredients, pharmaceutical intermediates, electronic materials and crop protection chemicals. It supplies raw materials and intermediates to global pharmaceutical and materials companies, including contract manufacturing for multinational clients using multi-step synthesis and large-scale reaction facilities. It also supplies semiconductor and display-related chemical materials, and it operates production in South Korea.
Written by AI from the company's latest annual report.
- Korean name
- 그린생명과학
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 양준화, 이기성(각자 대표이사)
- Founded
- Apr 2005
- Listed
- Dec 2009
- Listed shares
- 20,000,000
- Fiscal year ends
- Month 12
- Website
- www.kpxls.com/
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportJul 31, 2026
- New Facility Investment, etc.Jul 30, 2026
- 5%+ holding reportJul 29, 2026
- Change of largest shareholderJul 22, 2026
Titles in Korean until English translations are added.
Also known as: Green Lifescience / 그린생명과학 / 114450 / KRX:114450
Source: KRX statistical information